Stock Taper Net Income: $12.4 million ($1.52 per share), up from $11.3 million ($1.41 per share) in Q1 2026.
Loan Growth: Increased by $93 million (3.2% sequentially) to $3 billion, with new originations outpacing portfolio runoff.
Core Deposits: Grew by $128 million, including $72 million in noninterest-bearing and NOW accounts; year-to-date increase in annualized checking balances of approximately $68 million (17%).
Net Interest Margin: Expanded to 358 basis points, a 30 basis point increase from the prior quarter.
Noninterest Income: Totaled $3.3 million, with $2.4 million from SBA loan sales.
Credit Quality: Nonperforming loans decreased to $15.9 million, with a reserve coverage of 193%.
Return Metrics: Return on average assets (ROAA) at 1.46% and return on average tangible common equity (ROATCE) at 15.61%.
Continued success in the SBA division, contributing significantly to noninterest income.
Reduction of wholesale funding by $44 million this quarter, totaling a $520 million reduction (51%) since the end of 2022.
Focus on deepening relationships with existing customers rather than acquiring new ones, leading to increased loan origination.
Investments in talent and technology to support growth and enhance operating leverage.
Loan Growth: Revised full-year guidance to 5% to 7%.
Net Interest Income: Increased outlook to $115 million to $117 million.
Noninterest Income: Maintained guidance of $12 million to $13 million.
Noninterest Expense: Raised guidance to $65 million to $67 million, with an expectation that this will not negatively impact the efficiency ratio.
Anticipated continued margin expansion into Q3 2026.
The increase in noninterest expense may raise concerns about future profitability if not matched by revenue growth.
The competitive landscape in the health care lending sector is becoming more intense, which could pressure margins.
The bank's reliance on existing customer relationships for loan growth may pose risks if those relationships weaken or if economic conditions change.
Loan growth is primarily driven by deepening relationships with existing customers rather than acquiring new ones.
The bank is cautious about increasing brokered funding and expects it to decrease organically over time, though sub-10% levels may be aggressive.
There is a focus on maintaining a balance between expenses and revenue, with management emphasizing that increased expenses will correlate with performance.
The SBA division is being managed conservatively to mitigate risks, with no immediate plans to increase origination targets despite strong performance.
Management expressed confidence in maintaining strong profitability metrics, with no expected decrease unless external conditions change significantly.
SOURCE: Q2 2026 EARNINGS CALL TRANSCRIPT